Yüklüyor......
Varenicline in the treatment of tobacco dependence
Varenicline, a partial agonist of α(4)β(2) nicotinic acetylcholine receptors, is the most recently approved drug for smoking cessation. This paper reviews the outcomes of Phase 2 and Phase 3 clinical trials that assess the efficacy of varenicline in comparison to placebo and other smoking cessation...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2518383/ https://ncbi.nlm.nih.gov/pubmed/18728741 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|